Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL705989 | 0.97 | ESR1 (0.40) | ESR1ESR2ALDH1A1TSHRTDP1 | |
| SCHEMBL9320163 | 0.84 | — | — | |
| SCHEMBL49748 | 0.79 | ESR1 (0.36) | ESR1ESR2ALDH1A1TSHRTDP1 | |
| SCHEMBL704195 | 0.79 | ESR1 (0.36) | ESR1ESR2ALDH1A1TSHRTDP1 | |
| SCHEMBL464991 | 0.77 | ALDH1A1 (0.40) | ESR1ESR2ALDH1A1TSHRTDP1 | |
| SCHEMBL703156 | 0.76 | ESR1 (0.40) | ESR1ESR2ALDH1A1TSHRTDP1 | |
| SCHEMBL126319 | 0.74 | ESR1 (0.43) | ESR1ESR2ALDH1A1TSHRTDP1 | |
| SCHEMBL15975758 | 0.74 | ESR1 (0.43) | ESR1ESR2ALDH1A1TSHRTDP1 | |
| SCHEMBL103830 | 0.74 | ESR1 (0.43) | ESR1ESR2ALDH1A1TSHRTDP1 | |
| SCHEMBL12879524 | 0.74 | ESR1 (0.43) | ESR1ESR2ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010778-A | Preparation method of (S) -3-aminobutyric acid hydrochloride compound | 湖南阿斯迪康药业有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4724505-A1 | NON-COORDINATED ALKYLALUMINUM FREE ANION MODIFIED ALUMOXANES AND METHODS THEREOF | ExxonMobil Technology and Engineering Company (US) | 2026-04-15 | — | — | EP | claimed |
| EP-4724507-A1 | SOLUTION CATALYST SYSTEMS AND USES THEREOF | ExxonMobil Technology and Engineering Company (US) | 2026-04-15 | — | — | EP | claimed |
| WO-2024253829-A1 | SOLUTION CATALYST SYSTEMS AND USES THEREOF | ExxonMobil Technology and Engineering Company (US) | 2024-12-12 | — | — | WO | claimed |
| WO-2024253831-A1 | NON-COORDINATED ALKYLALUMINUM FREE ANION MODIFIED ALUMOXANES AND METHODS THEREOF | ExxonMobil Technology and Engineering Company (US) | 2024-12-12 | — | — | WO | claimed |
| US-20240238771-A1 | SUPPORTED RARE EARTH CATALYSTS AND CATALYTIC CH BORYLATION OF HYDROCARBONS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2024-07-18 | — | — | US | claimed |
| US-11769871-B2 | Lithium secondary batteries and nonaqueous electrolyte for use in the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-09-26 | — | — | US | claimed |
| CN-116495759-A | Method for preparing lithium fluoride by adopting fluorosilane compound | 广州天赐高新材料股份有限公司 | 2023-07-28 | — | — | CN | claimed |
| US-20210066707-A1 | LITHIUM SECONDARY BATTERIES AND NONAQUEOUS ELECTROLYTE FOR USE IN THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-03-04 | — | — | US | claimed |
| CN-107385956-A | The manufacture method of flower fabric in a kind of antiultraviolet water | 福建福田纺织印染科技有限公司 | 2017-11-24 | — | — | CN | claimed |
| US-6046293-A | Solid-liquid phase interfacial polymerization | UNIVERSITY OF SOUTH AUSTRALIA (AU) | 2000-04-04 | — | — | US | claimed |
| WO-2000008069-A1 | PROCESS FOR HYDROGENATING A CONJUGATED DIENE POLYMER | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2000-02-17 | — | — | WO | claimed |
| US-5523384-A | POLYMERIZING BISHALOARYL KETONES IN PRESENCE OF CATALYSTS CONTAINING ALKALI METAL SILONATE, HALOSILANE, OR SILANOL, ACOPPER COMPOUND CATALYST, OXYGEN SOURCE AND SOLVENT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-06-04 | — | — | US | claimed |
| EP-0067066-B2 | Dry-developing resist composition | FUJITSU LTD (JP) | 1994-01-12 | — | — | EP | claimed |
| EP-0067066-B1 | DRY-DEVELOPING RESIST COMPOSITION | FUJITSU LIMITED (JP) | 1985-12-18 | — | — | EP | claimed |
| EP-0067067-B1 | DRY-DEVELOPING NEGATIVE RESIST COMPOSITION | FUJITSU LIMITED (JP) | 1985-09-25 | — | — | EP | claimed |
| US-4481279-A | Dry-developing resist composition | FUJITSU LIMITED (JP) | 1984-11-06 | — | — | US | claimed |
| US-4464455-A | Dry-developing negative resist composition | FUJITSU LIMITED (JP) | 1984-08-07 | — | — | US | claimed |
| EP-0067066-A2 | Dry-developing resist composition | FUJITSU LIMITED (JP) | 1982-12-15 | — | — | EP | claimed |
| EP-0067067-A2 | Dry-developing negative resist composition | FUJITSU LIMITED (JP) | 1982-12-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238771-A1 | SUPPORTED RARE EARTH CATALYSTS AND CATALYTIC CH BORYLATION OF HYDROCARBONS | HAO2, SCO2, SOD1 | ESR1 465/4885ESR2 359/4885ALDH1A1 2963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.